Contrast Media Injectors Market Report 2019: Worldwide Forecasts to 2024 - IT-enabled Solutions Present Lucrative Opportunities
DUBLIN, Sept. 24, 2019 /PRNewswire/ -- The "Contrast Media Injectors Market by Product (Injector Systems (CT Injector, MRI Injector), Consumables (Injector Heads, Syringes), Accessories), Application (Radiology, Interventional Cardiology), & End Users (Hospitals) - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The contrast media injectors market is projected to reach USD 1.83 billion by 2024 from USD 1.33 billion in 2019, at a CAGR of 6.1% during the forecast period.
Factors such as the growing prevalence of cancer and CVD; a large number of approvals for contrast agents; and increasing investments, funds, and grants by government organizations are driving the growth of the contrast media injectors market. However, the high cost of contrast media injectors and consumables & accessories is restraining the growth of the market to a certain extent.
The consumables segment is expected to witness the highest growth rate during the forecast period of the contrast media injector market
Based on the product, the contrast media injectors market is segmented into injector systems, consumables, and accessories. The injector systems market is segmented further into CT injectors, MRI injectors, Angiography injectors. The consumables segment is segmented further into injector heads, syringes, tubes, and other consumables. The consumables segment is expected to witness the highest growth rate during the forecast period. The high growth rate in this segment can be attributed to the growing requirement of consumables to maintain safety and hygienic conditions during diagnostic procedures. These consumables need to be re-purchased for every new procedure as opposed to instruments.
The interventional cardiology segment will continue to dominate the contrast media injector applications market during the forecast period.
Based on application, the contrast media injectors market is segmented into radiology, interventional radiology, and interventional cardiology. In 2018, the interventional cardiology segment had the highest growth rate of the contrast media injectors market. The rising number of the high prevalence of CVD is driving the growth of this application segment.
The hospital segment will continue to dominate the contrast media injector end-user market during the forecast period.
Based on end-user, the contrast media injectors market is segmented into hospitals and diagnostic imaging centers. The hospital segment commanded the highest growth rate of the global contrast media injectors market in 2018. The large share of this segment can be attributed to the rising number of diagnostic imaging procedures performed in hospitals and the growing inclination of hospitals towards the automation and digitization of radiology patient workflow. Increasing adoption of minimally invasive procedures (including diagnostic imaging systems) in hospitals to improve the quality of patient care, and the rising adoption of advanced imaging modalities to improve workflow efficiency in hospitals will also drive market growth.
The contrast media injector market in Asia Pacific is expected to witness the highest growth rate during the forecast period.
Geographically, the contrast media injector market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The Asia Pacific market is expected to grow at the highest CAGR during the forecast period, primarily due to factors such as the rising R&D investments and favorable demographic scenario in China, rising aging population and cancer incidence in Japan. Growing investment in the Indian radiology market and increasing focus of market players & increasing government support to strengthen healthcare service delivery in other countries are driving the growth of this regional segment.
Competitive Landscape
Major players in this market include are Bayer AG (Germany), Bracco Imaging S.P.A (Italy), Guerbet Group (France), Ulrich GmbH & Co. KG (Germany), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical-Device Technology Co., Ltd. (Sinomdt) (China), APOLLO RT Co. Ltd. (Hongkong), Shenzhen Anke High-tech Co. Ltd. (China), Shenzen Seacrown Electromechanical Co. Ltd. (China), and Medtron AG (Germany).
Key Topics Covered
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Contrast Media Injectors: Market Overview
4.2 Market, By Product, 2019 vs 2024 (USD Million)
4.3 Market, By Application, 2019 vs 2024 (USD Million)
4.4 Market: Geographic Growth Opportunities
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.3 Drivers
5.3.1 Growing Prevalence of Cancer and CVD
5.3.2 Large Number of Approvals for Contrast Agents
5.3.3 Increasing Investments, Funds, and Grants By Government Organizations
5.4 Restraints
5.4.1 High Cost of Contrast Media Injectors, Consumables, & Accessories
5.5 Opportunities
5.5.1 IT-Enabled Solutions for Contrast Media Injectors
5.6 Challenges
5.6.1 Hospital Budget Cuts
5.6.2 Dearth of Trained Professionals
6 Contrast Media Injectors Market, By Product
6.1 Introduction
6.2 Consumables
6.2.1 Injector Heads
6.2.1.1 Single-Head Injectors
6.2.1.1.1 North America Accounted for the Largest Share of This Market in 2018
6.2.1.2 Dual-Head Injectors
6.2.1.2.1 Dual-Head Injectors are Efficient in Terms of Contrast Delivery and Avoid Air Embolisms
6.2.1.3 Syringeless Injectors
6.2.1.3.1 Market Players have Introduced Syringeless Injectors Compatible With Imaging Modalities
6.2.2 Syringes
6.2.2.1 APAC is Expected to Grow at the Highest CAGR During the Forecast Period
6.2.3 Tubes
6.2.3.1 Depending on Their Intended Use, Contrast Media Injector Tubes Come in Various Shapes and Sizes
6.2.4 Other Consumables
6.3 Injector Systems
6.3.1 CT Injectors
6.3.1.1 Increasing Number of CT Scans to Boost Market Growth
6.3.2 MRI Injectors
6.3.2.1 Launch of Technologically Advanced MRI Injectors to Drive Market Growth
6.3.3 Angiography Injectors
6.3.3.1 Rising Number of CVD to Propel Market Growth
6.4 Accessories
7 Contrast Media Injectors Market, By Application
7.1 Introduction
7.2 Radiology
7.2.1 Rising Number of Radiology Procedures Using Contrast Media to Drive Market Growth
7.3 Interventional Cardiology
7.3.1 Rising Burden of CVD to Drive Market Growth
7.4 Interventional Radiology
7.4.1 Increasing Need for Minimally Invasive Procedures Likely to Bolster Market Growth
8 Contrast Media Injectors Market, By End User
8.1 Introduction
8.2 Hospitals
8.2.1 Adoption of Diagnostic Imaging Modalities Across Hospitals Likely to Drive Market Growth
8.3 Diagnostic Imaging Centers
8.3.1 Increasing Number of Private Imaging Centers is Contributing to Market Growth
9 Contrast Media Injectors Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 US Dominated the North American Market in 2018
9.2.2 Canada
9.2.2.1 Rise in the Number of Investments Towards Improving Medical Imaging -A Major Factor Driving Market Growth in Canada
9.3 Europe
9.3.1 Germany
9.3.1.1 Well-Developed Diagnostic Imaging Infrastructure is A Major Factor Driving Market Growth in Germany
9.3.2 UK
9.3.2.1 Although Running on Outdated Equipment, the UK Healthcare System has Seen Fresh Funding for Upgradation
9.3.3 France
9.3.3.1 France has A Low Installed Base of Imaging Devices
9.3.4 Italy
9.3.4.1 Growing Prevalence of Cancer and Obesity Will Drive Demand for Diagnostic Procedures in Italy
9.3.5 Spain
9.3.5.1 Shortage of Radiologists in the Country to Restrain Market Growth
9.3.6 Rest of Europe
9.4 Asia Pacific (APAC)
9.4.1 Japan
9.4.1.1 Rising Aging Population and Cancer Incidence to Drive Market Growth in Japan
9.4.2 China
9.4.2.1 High Cancer and Stroke Incidence is Driving Market Growth in China
9.4.3 Rest of Asia Pacific
9.5 Rest of the World
9.5.1 Latin America
9.5.1.1 Initiatives to Modernization Healthcare are Likely to Boost Market Growth in the Region
9.5.2 Middle East & Africa
9.5.2.1 Poor Reimbursement System and Lack of Proper Healthcare Infrastructure to Restrain the Market Growth
10 Competitive Landscape
10.1 Overview
10.2 Market Ranking Analysis
10.3 Competitive Leadership Mapping
10.3.1 Visionary Leaders
10.3.2 Innovators
10.3.3 Dynamic Differentiators
10.3.4 Emerging Companies
10.4 Competitive Scenario
10.4.1 Product Launches & Approvals
10.4.2 Expansions
10.4.3 Acquisitions
10.4.4 Partnerships
11 Company Profiles
11.1 Bayer AG
11.2 Bracco Imaging S.P.A
11.3 Guerbet Group
11.4 Shenzhen Anke High-Tech Co. Ltd.
11.5 Nemoto Kyorindo Co. Ltd.
11.6 Sino Medical Device Technology Co. Ltd. (Sinomdt)
11.7 Apollo Rt Co. Ltd.
11.8 Shenzen Seacrown Electromechanical Co. Ltd.
11.9 Ulrich GmbH & Co. KG
11.10 Medtron AG
For more information about this report visit https://www.researchandmarkets.com/r/ua2ymn
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article